Literature DB >> 2623642

Etiology of retinoic acid-induced cleft palate varies with the embryonic stage.

B D Abbott1, M W Harris, L S Birnbaum.   

Abstract

Retinoic acid (RA) has been shown to be teratogenic in many species, and 13-cis-RA is teratogenic in humans. Exposure to RA during embryonic morphogenesis produced a variety of malformations including limb defects and cleft palate. The type and severity of malformation depended on the stage of development exposed. The purpose of this study was to compare the effects of RA exposure in vivo on different stages of palate development. These results were compared to effects observed after exposure in organ culture. The vehicle used in RA dosing was also shown to be a major factor in the incidence of RA-induced cleft palate. For the in vivo studies, RA (100 mg/kg) in 10 ml corn oil/kg was given p.o. on gestation day (GD) 10 or 12, and the embryos were examined on GD 14 and 16. Exposure to RA in an oil:DMSO vehicle resulted in much higher incidences of cleft palate than were observed after dosing with RA in oil only. After exposure on GD 10, to RA, small palatal shelves formed which did not make contact and fuse on GD 14. The medial cells did not undergo programmed cell death. Instead, the medial cells differentiated into a stratified, squamous, oral-like epithelium. The RA-exposed medial cells did not incorporate 3H-TdR on GD 14 or 16, but the cells expressed EGF receptors and bound 125I-EGF. In contrast, RA-induced clefting after exposure on GD 12 did not involve growth inhibition. Shelves of normal size formed and made contact, but because of altered medial cell differentiation did not fuse. Medial cells differentiated into a pseudostratified, ciliated, nasal-like epithelium. This response was produced in vivo at exposure levels which produced cleft palate, and after exposure of palatal shelves to RA in vitro from GD 12-15. The medial cells exposed on GD 12 incorporated 3H-TdR on GD 14, expressed EGF receptors, and bound 125I-EGF. The responses to RA which lead to cleft palate differed after exposure on GD 10 or 12, and the pathways of differentiation which the medial cells followed depended on the developmental stage exposed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2623642     DOI: 10.1002/tera.1420400602

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  21 in total

1.  Computational Model of Secondary Palate Fusion and Disruption.

Authors:  M Shane Hutson; Maxwell C K Leung; Nancy C Baker; Richard M Spencer; Thomas B Knudsen
Journal:  Chem Res Toxicol       Date:  2017-01-20       Impact factor: 3.739

2.  The retinaldehyde reductase DHRS3 is essential for preventing the formation of excess retinoic acid during embryonic development.

Authors:  Sara E Billings; Keely Pierzchalski; Naomi E Butler Tjaden; Xiao-Yan Pang; Paul A Trainor; Maureen A Kane; Alexander R Moise
Journal:  FASEB J       Date:  2013-09-04       Impact factor: 5.191

3.  Copy Number Changes Identified Using Whole Exome Sequencing in Nonsyndromic Cleft Lip and Palate in a Honduran Population.

Authors:  Yi Cai; Karynne E Patterson; Frederic Reinier; Sarah E Keesecker; Elizabeth Blue; Michael Bamshad; Joseph Haddad
Journal:  Birth Defects Res       Date:  2017-07-27       Impact factor: 2.344

4.  A preliminary study on the teratogenesis of dexamethasone and the preventive effect of vitamin B12 on murine embryonic palatal shelf fusion in vitro.

Authors:  Sheng-jun Lu; Wei He; Bing Shi; Tian Meng; Xiao-yu Li; Yu-rong Liu
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

5.  P1 and cosmid clones define the organization of 280 kb of the mouse H-2 complex containing the Cps-1 and Hsp70 loci.

Authors:  D L Gasser; N L Sternberg; J C Pierce; A Goldner-Sauve; H Feng; A K Haq; T Spies; C Hunt; K H Buetow; D D Chaplin
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Retinoic acid drives aryl hydrocarbon receptor expression and is instrumental to dioxin-induced toxicity during palate development.

Authors:  Hugues Jacobs; Christine Dennefeld; Betty Féret; Matti Viluksela; Helen Håkansson; Manuel Mark; Norbert B Ghyselinck
Journal:  Environ Health Perspect       Date:  2011-08-01       Impact factor: 9.031

7.  Characterizing cleft palate toxicants using ToxCast data, chemical structure, and the biomedical literature.

Authors:  Nancy C Baker; Nisha S Sipes; Jill Franzosa; David G Belair; Barbara D Abbott; Richard S Judson; Thomas B Knudsen
Journal:  Birth Defects Res       Date:  2019-08-30       Impact factor: 2.661

8.  Retinoic acid alters the proliferation and survival of the epithelium and mesenchyme and suppresses Wnt/β-catenin signaling in developing cleft palate.

Authors:  X Hu; J Gao; Y Liao; S Tang; F Lu
Journal:  Cell Death Dis       Date:  2013-10-31       Impact factor: 8.469

9.  MicroRNA-124-3p Plays a Crucial Role in Cleft Palate Induced by Retinoic Acid.

Authors:  Hiroki Yoshioka; Yurie Mikami; Sai Shankar Ramakrishnan; Akiko Suzuki; Junichi Iwata
Journal:  Front Cell Dev Biol       Date:  2021-06-09

10.  6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells.

Authors:  Rodica P Bunaciu; Holly A Jensen; Robert J MacDonald; Dorian H LaTocha; Jeffrey D Varner; Andrew Yen
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.